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Abstract Most quantitative trait loci (QTL) studies fail to
account for the effect that the maternal genotype may have
on an individual’s phenotypes, even though maternal effect
QTL have been shown to account for considerable varia-
tion in growth and obesity traits in mouse models. More-
over, the fetal programming theory suggests that maternal
effects inﬂuence an offspring’s adult ﬁtness, although the
genetic nature of fetal programming remains unclear.
Within this context, our study focused on mapping geno-
mic regions associated with maternal effect QTL by ana-
lyzing the phenotypes of chromosomes 2 and 7
subcongenic mice from genetically distinct dams. We
analyzed 12 chromosome 2 subcongenic strains that
spanned from 70 to 180 Mb with CAST/EiJ donor regions
on the background of C57BL/6 J, and 14 chromosome 7
subcongenic strains that spanned from 81 to 111 Mb with
BALB/cByJ donor regions on C57BL/6ByJ background.
Maternal QTL analyses were performed on the basis of
overlapping donor regions between subcongenic strains.
We identiﬁed several highly signiﬁcant (P\5 9 10
-4)
maternal QTL inﬂuencing total body weight, organ weight,
and fat pad weights in both sets of subcongenics. These
QTL accounted for 1.9-11.7% of the phenotypic variance
for growth and obesity and greatly narrowed the genomic
regions associated with the maternal genetic effects. These
maternal effect QTL controlled phenotypic traits in adult
mice, suggesting that maternal inﬂuences at early stages of
development may permanently affect offspring perfor-
mance. Identiﬁcation of maternal effects in our survey of
two sets of subcongenic strains, representing approxi-
mately 5% of the mouse genome, supports the hypothesis
that maternal effects represent signiﬁcant sources of
genetic variation that are largely ignored in genetic studies.
Introduction
Growth and obesity are complex phenotypic traits with a
moderate to strong genetic basis in mammals (Bouchard
1991; Mignon-Grasteau et al. 2000), and both traits are
linked to health disorders in humans and domestic animals
(Bouchard 1991; Brindley and Rolland 1989; Lew and
Garﬁnkel 1979). Mouse models have provided valuable
insight into the genetic architecture of growth and obesity
through the identiﬁcation of single-gene mutations (de
Magalha ˜es et al. 2005; Horvat and Medrano 2001; Zhang
et al. 1994), quantitative trait loci (QTL) (Corva and
Medrano 2001; Farber and Medrano 2007; Warden et al.
1995), epistatic interactions between different genomic
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DOI 10.1007/s00335-009-9182-9regions (Brockmann et al. 2000), and quantiﬁcation of the
additive genetic variance (Maes et al. 1997).
Genetic analyses of growth and obesity traits in mice
have typically focused on direct genetic effects without
taking into account the effects of the maternal genotype.
Some studies support the importance of maternal genetic
contributions (Jarvis et al. 2005; Wolf et al. 2002), but they
only broadly characterized the effects and have not local-
ized associated genomic regions (Jarvis et al. 2005). Recent
studies focusing on the identiﬁcation of QTL for growth
and obesity have suggested the presence of maternal effects
on chromosomes 2 and 7 in two sets of subcongenic strains
(Diament and Warden 2004; Farber and Medrano 2007). In
the present study we further investigate each subcongenic
set using a QTL ﬁne-mapping approach focused on the
overlapping donor regions to identify maternal QTL
affecting the phenotypes in adulthood.
The analysis of maternal effects that inﬂuence traits in
adults has become a major ﬁeld of research in recent years,
characterizing a biological phenomenon known as fetal
programming (Schwartz and Morrison 2005). The fetal
programming hypothesis proposes that alterations in
fetal or early neonatal nutrition and endocrine status result
in developmental adaptations that permanently change
structure, physiology, and metabolism (Barker 1998),
inﬂuencing both adult health (Godfrey and Barker 2001)
and phenotypic performance (Wu et al. 2006). Fetal
programming has been associated with atherosclerosis
(Goharkhay et al. 2007), obesity (Yura et al. 2005), car-
diovascular disease (Remacle et al. 2004), and fertility
(Abbott et al. 2006) in mouse, although little is known
about the genetic architecture of these maternal inﬂuences.
The analysis of the putative genetic mechanisms regulating
fetal programming in mice could contribute useful infor-
mation to the understanding of the genetic basis of growth
and obesity in mammals.
Materials and methods
Mouse husbandry
Two independent sets of subcongenic mouse strains with
donor regions on chromosomes 2 and 7 (Figs. 1 and 2)
were developed as described by Farber and Medrano
(2007) and Warden et al. (1995), and maintained in dif-
ferent vivariums at the University of California-Davis.
Note that these were independent mouse populations
developed and maintained under different management
conditions (e.g., facility, diet; see below). Mice were
housed in groups of two to ﬁve in polycarbonate cages
bedded with a 2:1 mixture of CareFRESH (Absorption
Corp., Ferndale, WA) and soft paper chips (Canbrands
Intl., Moncton, Canada) and maintained under controlled
conditions of temperature (21 ± 2C), humidity (40–70%),
and lighting (14 h light, 10 h dark, lights on at 7 a.m.).
Mice were weaned at 3 weeks of age. Chromosome 2
subcongenic strains (and founder stains) were fed with
Purina Laboratory Rodent Diet 5008 (Labdiet
, Purina
Mills, Inc., St. Louis, MO; 23.5% protein, 6.5% fat,
3.3 kcal/g), whereas chromosome 7 subcongenic mice
were fed Research Diets AIN-76A (Research Diets, Inc.,
New Brunswick, NJ; 20.8% protein from casein, 67.7%
carobydrate from sucrose, 11.5% fat from corn oil,
3.9 kcal/g). Food and water were offered ad libitum. All
mouse protocols were managed according to the guidelines
of the American Association for Accreditation of Labora-
tory Animal Care (AAALAC; http://www.aaalac.org).
Genotyping
During the development of chromosome 2 subcongenic
strains, mice were genotyped for 36 microsatellite loci
(D2Mit329, D2Mit93, D2Mit94, D2Mit160, D2Mit476,
D2Mit15, D2Mit439, D2Mit130, D2Mit389, D2Mit43,
D2Mit477, D2Mit185, D2Mit58, D2Mit207, D2Mit101,
D2Mit420, D2Mit445, D2Mit17, D2Mit224, D2Mit107,
D2Mit488, D2Mit223, D2Mit136, D2Mit490, D2Mit212,
D2Mit194, D2Ucd22, D2Mit260, D2Mit286, D2Mit409,
D2Mit262, D2Mit196, D2Mit342, D2Mit456, D2Mit213,
and D2Mit148; Table 1) and the nonagouti locus. DNA
samples were isolated from 1.0-mm tail clips and geno-
typed following standard PCR protocols as described by
Farber et al. (2006). Chromosome 7 subcongenic strains
were genotyped by standard PCR protocols for ten
microsatellite loci (D7Mit318, D7Mit90, D7Mit62,
D7Mit301, D7Mit373, D7Mit321, D7Mit354, D7Mit353,
D7Mit96, and D7Mit37; Table 1) after extracting DNA
samples from kidney or toe (Diament and Warden 2004).
Marker D7Mit37 is placed as the most distal marker by the
Ensembl genome browser (Ensembl; http://www.ensembl.
org) and by the National Center for Biotechnology Infor-
mation (NCBI; http://www.ncbi.nlm.nih.gov), whereas
Celera (http:www.celera.com) assumes two copies, one
placed in the distal location and the other one placed
between markers D7Mit373 and D7Mit321. Our analyses
were performed on the basis of D7Mit37 placed at the most
distal position.
Subcongenic F2 crosses
For mouse chromosome 2, seven subcongenic strains were
developed from the B6.CAST-(D2Mit329-D2Mit457)N(6)
congenic strain (B62D) (Farber and Medrano 2007; Farber
et al. 2006). Five additional subcongenic strains were
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123generated on the basis of the HG.CAST-(D2Mit329-
D2Mit457)N(6) congenic line (HG2D) (R. J. Gularte,
personal communication), following the procedures
detailed by Farber and Medrano (2007). Both B62D and
HG2D possessed identical CAST/EiJ donor regions intro-
gressed on C57BL6/J (B6) and C57BL/6 J-hg/hg (HG)
(Corva and Medrano 2000) backgrounds, respectively.
Note that the HG strain is isogenic to B6, except for the
high growth locus, a 500-kb deletion on mouse chromo-
some 10 (Horvat and Medrano 2001). As described by
Farber and Medrano (2007), seven B6 9 (B62D 9 B6)
males with narrow (approximately 20 Mb) overlapping
donor regions were selected and backcrossed to B6 females
to generate large numbers of F1 heterozygous mice of both
sexes. Subcongenic F2 populations were created by inter-
mating F1 heterozygous mice derived from each of
the seven founders. In a similar way, the F2 HG2D
subcongenic populations were generated from ﬁve
HG 9 (HG2D 9 HG) males with narrow overlapping
donor regions mated with HG females and the subsequent
mating of heterozygous F1 individuals (R. J. Gularte, per-
sonal communication). See Table 2 and Fig. 1 for a
detailed characterization of F2 populations and donor
regions.
Subcongenic strains for mouse chromosome 7 were
developed from the BALB/cByJ (B6.C-H1) congenic strain
(The Jackson Laboratory, Bar Harbor, ME, USA), a com-
mercially available strain retaining the H1 histocompati-
bility antigen allele of the BALB/cBy strain on the
background of the C57BL/6ByJ (B6By) strain. Fourteen
subcongenic strains were generated by backcrossing
B6By 9 B6.C-H1 mice to B6By mice. Then, each
recombinant mouse containing only a part of the full
congenic region was backcrossed again to B6By and gen-
otyped to produce F1 progeny with identical recombinant
donor region boundaries. These heterozygous progeny
were sib-mated to produce F2 littermate mice of all three
genotype classes (Diament and Warden 2004). The geno-
mic intervals captured by each subcongenic strain are
summarized in Fig. 2 and Table 2.
Recording of phenotypic data
Genotypes were available for mice in all generations (F0,
F1, and F2) and phenotypic information was collected from
all F2 mice from each subcongenic. Chromosome 2 sub-
congenic male and female mice were weighed at 2 (2WK),
3 (3WK), 6 (6WK), and 9 (9WK) weeks of age. At sac-
riﬁce (9WK ± 5 days), mice were weighed, anesthetized
under isoﬂuorane, sacriﬁced by decapitation, and exsan-
guinated. The weight of liver (LW), spleen (SW), kidneys
(KW), heart (HW), and testis (TW) were registered.
Gonadal fat pads (GFP; adipose tissue surrounding the
gonads and other reproductive organs), retroperitoneal fat
pad (RFP; fat deposit behind each kidney along the lumbar
muscles), mesenteric fat pad (MFP; adipose tissue sur-
rounding the gastrointestinal tract from the gastroesopha-
geal sphincter to the end of the rectum), and femoral fat
pads (FFP; subcutaneous adipose deposit from the outer
thigh) were dissected following Johnson and Hirsch
(1972). Total fat pad weight (TFP) was calculated as the
sum of GFP, RFP, MFP, and FFP. At 16–18 weeks of age,
chromosome 7 subcongenic male mice were anesthetized
with isoﬂuorane and measurements of body length (BL)
and weight (BW) were taken. Animals were sacriﬁced by
cervical dislocation. After sacriﬁce, carcass weight (CW)
was registered and gonadal, retroperitoneal, mesenteric,
and femoral fat pads were dissected and weighed as
described by Warden et al. (1995). See Tables 2 and 3 for
a detailed summary of available mice and phenotypic
records.
Table 1 Microsatellite markers typed in the chromosome 2 and
chromosome 7 subcongenic strains
Marker Mb
a Marker Mb
a
Chromosome 2 D2Mit212 141.8
D2Mit329 74.9 D2Mit194 143.8
D2Mit93 76.7 D2Ucd22 146.0
D2Mit94 80.0 D2Mit260 149.0
b
D2Mit160 84.8 D2Mit286 154.3
D2Mit476 86.3 Nonagouti 154.8
D2Mit15 91.9 D2Mit409 158.3
D2Mit439 92.0 D2Mit262 155.7
D2Mit130 97.4 D2Mit196 160.3
D2Mit389 103.1 D2Mit342 164.7
D2Mit43 104.0 D2Mit456 168.8
D2Mit477 104.4 D2Mit213 174.4
D2Mit185 105.3 D2Mit148 178.5
D2Mit58 108.1
D2Mit207 112.0 Chromosome 7
D2Mit101 114.9 D7Mit318 81.1
D2Mit420 118.1
b D7Mit90 87.5
D2Mit445 121.1 D7Mit62 91.8
D2Mit17 122.6
b D7Mit301 98.7
D2Mit224 129.1 D7Mit373 103.2
D2Mit107 133.1 D7Mit321 105.1
D2Mit488 133.1 D7Mit354 106.1
D2Mit223 134.7
b D7Mit353 106.7
D2Mit136 136.2 D7Mit96 107.7
D2Mit490 138.7 D7Mit37 111.0
a Mb according to Ensembl genome browser (http://www.
ensembl.org) April 2007 assembly (Hubbard et al. 2002)
b Mb according to UCSC Genome Bioinformatics (http://genome.
ucsc.edu) July 2007 assembly (Karolchik et al. 2003)
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As shown in Figs. 1 and 2, the donor regions of sub-
congenic strains with donor regions on the same chro-
mosome partially overlapped. This property allowed us to
deﬁne 22 overlapping regions (OR) on chromosome 2 and
15 OR on chromosome 7 (see Figs. 1 and 2). Note that
OR were sequentially numbered from 2.1 to 2.22 in
chromosome 2 (Fig. 1) and from 7.1 to 7.15 in chromo-
some 7 (Fig. 2). Although previous analyses performed on
these data modeled maternal genetic contributions on the
broad basis of each subcongenic strain (Diament and
Warden 2004; Farber and Medrano 2007), the OR
approach allowed ﬁne-mapping (*10 Mb) of maternal
QTL by examining differences between background/
background and donor/background F1 females (mothers of
the F2 population) at each genomic location. As was
initially applied by Clee et al. (2006) on a direct QTL,
this analysis extends the method for QTL mapping by
allowing for strain differences at each OR. The speciﬁc
genetic architecture of our subcongenic strains was used
Table 2 Summary of the
subcongenic F2 crosses and their
congenic regions
N Males Females Litters Boundary microsatellites of the congenic region
Chromosome 2 subcongenics
B62D-1 87 87 0 15 D2Mit329 D2Mit476
B62D-2 128 128 0 19 D2Mit94 D2Mit101
HG2D-1 363 159 204 52 D2Mit43 D2Mit103
B62D-3 157 157 0 25 D2Mit477 D2Mit103
B62D-4 145 145 0 24 D2Mit207 D2Mit17
HG2D-2 233 95 138 27 D2Mit420 D2Mit490
B62D-5 111 111 0 21 D2Mit445 D2Mit107
B62D-6 118 118 0 17 D2Mit107 D2Mit194
B62D-7 129 129 0 22 D2Mit490 D2Mit409
HG2D-3 371 189 182 47 D2Mit194 D2Mit262
HG2D-4 336 166 170 38 D2Mit286 D2Mit213
HG2D-5 377 170 207 50 D2Mit456 D2Mit148
Overall 2555 1654 901 357
Chromosome 7 subcongenics
B6.C-H1 51 51 0 31 D7Mit318 D7Mit37
B6.C-C 76 76 0 44 D7Mit318 D7Mit318
B6.C-D 24 24 0 14 D7Mit18 D7Mit90
B6.C-M 36 36 0 22 D7Mit90 D7Mit90
B6.C-N 86 86 0 51 D7Mit90 D7Mit62
B6.C-L 33 33 0 19 D7Mit62 D7Mit301
B6.C-A 47 47 0 31 D7Mit 301 D7Mit301
B6.C-B 29 29 0 20 D7Mit301 D7Mit37
B6.C-I 88 88 0 44 D7Mit373 D7Mit373
B6.C-F 123 123 0 71 D7Mit373 D7Mit37
B6.C-H 48 48 0 26 D7Mit37 D7Mit37
B6.C-J 57 57 0 36 D7Mit37 D7Mit37
B6.C-K 29 29 0 14 D7Mit37 D7Mit37
B6.C-E 22 22 0 13 D7Mit321 D7Mit321
B6.C-G 31 31 0 14 D7Mit354 D7Mit354
Overall 780 780 0 450
Fig. 1 Summary of the maternal QTL in mouse chromosome 2.
Bottom Locations of the subcongenic strains and boundary markers
(red areas represent CAST/EiJ alleles and gray areas represent
C57BL6/J alleles; alleles residing between adjacent markers typed as
CAST/EiJ and C57BL6/J are undetermined and highlighted in blue;
only boundary markers are included). Top P-value plots for maternal
QTL affecting body weight (2WK, 3WK, 6WK, and 9WK, i.e., body
weight at 2, 3, 6, and 9 weeks of age, respectively), organ (LW liver
weight, SW spleen weight, KW kidneys weight, HW heart weight, TW
testis weight), and fat pads weight (GFP gonadal fat pads, RFP
retroperitoneal fat pad, MFP mesenteric fat pad, FFP femoral fat
pads, TFP total fat pads weight). The dotted horizontal line represents
the signiﬁcance threshold under Bonferroni’s correction (a = 0.05;
P = 1.62 9 10
-4)
c
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relation to the maternal genetic background within each
overlapping region. For chromosome 2, 22 analyses
focused on each overlapping region were performed for
14 phenotypic traits (Fig. 1) using the following mixed
model,
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þ eijklmno
where yijklmno and eijklmno were the phenotypic record and
residual term belonging to the oth mouse, respectively. This
model accounts forthe random environmental effect of each
dam (di), the genotype of the offspring in the overlapping
chromosomal regions (background/background, back-
ground/donor, or donor/donor; OORj), dam genotype in the
chromosomal overlapping region (background/donor or
background/background; DORk), genotype for the high-
growth locus (high growth or wild type; HGl), subcongenic
strain(12strains;SSm),sex(maleorfemale;SXn)andageat
sacriﬁce (ASo) as continuous effect. Preliminary analyses of
fat pad weights also accounted for weight at sacriﬁce,
althoughthisfactorwasdroppedfromtheoperational model
because it did not reach statistical signiﬁcance when com-
pared with age at sacriﬁce. On chromosome 2, maternal
Fig. 2 Summary of the maternal QTL in mouse chromosome 7.
Bottom Locations of the subcongenic strains and boundary markers
(red areas represent B6.C-Tyr
cH1
bHbb
d/By alleles and gray areas
represent C57BL/6ByJ alleles; alleles residing between adjacent
markers typed as B6.C-Tyr
cH1
bHbb
d/By and C57BL/6ByJ are
undetermined and highlighted in blue; only boundary markers are
included). Top P-value plots for maternal QTL affecting body size
(BL body length, BW body weight, CW carcass weight) and fat pads
weight (GFP gonadal fat pads, RFP retroperitoneal fat pad, MFP
mesenteric fat pad, FFP femoral fat pads, TFP total fat pads weight).
The spotted horizontal line highlights the signiﬁcance threshold under
Bonferroni’s correction (a = 0.05; P = 4.46 9 10
-4)
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inﬂuences related to the dam) and DORk (genetic effects
restricted to the analyzed chromosomal overlapping region)
effects,whereasdirectgeneticeffectswereinferredbyOORj
(loci located in the analyzed chromosomal overlapping
region), HGl (high-growth genotype), and SSm (genetic
background of each subcongenic strain) or accumulated in
the residual term (eijklmno). The separation of maternal and
direct genetic sources of variation was accomplished by
includingthetwofactorsDORkandOORjinthemodel;both
of this factors could be partially correlated. The same oper-
ational model was used to analyze chromosome 7 subcon-
genicstrainsbutwithouttheHGlterm,sincethehigh-growth
mutation was not present in B6.C-H1 mice. For both chro-
mosomes 2 and 7 subcongenic strains, an independent
analysis was sequentially performed on each chromosomal
overlapping region (note that overlapping regions 7.12 and
7.14 were contributed by the same subcongenic strains with
donor genotype: B6.C-H1, B6.C-B, B6.C-F, B6.C-J, and
B6.C-K; Fig. 2). Inference was focused on DORk in order to
scan maternal QTL with effects on growth and obesity traits
in mice. Although di could also capurate some genetic var-
iabilityduetomutations(CasellasandMedrano2008)inthe
background genome, its main effect must be due to envi-
ronmental sources of variation and without additional con-
tributions to the maternal QTL.
When the QTL scan detected two or more signiﬁcant
peaks for a given trait, the appropriate DORk effects asso-
ciated with the minimum P-value locations were jointly
analyzed in the same model (with the remaining systematic
andrandomsourcesofvariationdeﬁnedabove)todetermine
their statistical relevance in this population of congenic
mice. All analyses were performed with the Mixed proce-
dure of SAS 8.2 (SAS Institute, Inc., Cary, NC). Given that
these analyses were performed within a multiple-testing
scheme, Bonferroni’s correction was applied (a = 0.05).
Threshold for statistical signiﬁcance was placed at
P = 1.62 9 10
-4 (chromosome 2) and P = 4.46 9 10
-4
(chromosome 7).
Results
Maternal QTLs for growth and organ weight in mouse
chromosomes 2 and 7
A signiﬁcant QTL was detected for 9WK (P = 1.23 9
10
-5; Fig. 1) within the chromosomal region ﬂanked by
markers D2Mit477 and D2Mit207 (OR 2.5). The remaining
growth traits (2WK, 3WK, and 6WK) had similar P-value
proﬁles but failed to reach statistical signiﬁcance after
correcting for multiple testing. The peak additive effect
was negative (-0.828 ± 0.233 g), indicating that maternal
CAST/EiJ alleles reduced adult weight at 9 weeks in the
offspring.
All organ weights showed signiﬁcant maternal QTL on
mousechromosome2withtheexceptionofheart(P[0.23;
Fig. 1). Two maternal QTL were detected for KW between
D2Mit329 and D2Mit94 (P = 8.55 9 10
-8; OR 2.1) and
between D2Mit107 and D2Mit194 (P = 1.12 9 10
-6;O R
2.13–2.15), with positive and negative effects for CAST/EiJ
alleles on organ weight, respectively (Table 4). In a similar
way, two maternal QTL with opposite effects were obtained
for TW between D2Mit477 and D2Mit101 (P = 6.32 9
10
-7; OR 2.5–2.6) and between D2Mit107 and D2Mit194
(P = 6.96 9 10
-8; OR 2.13–2.15). For both KW and TW,
the two maternal QTL were corroborated under joint
analyses with P B 7.21 9 10
-5 for all cases. The two
remaining organs (LW and SW) showed a unique maternal
QTL between markers D2Mit477 and D2Mit101
(P = 3.50 9 10
-7 and P = 1.46 9 10
-7, respectively; OR
2.5 and 2.6),although slightlydifferingin the location of the
P-value peak (between D2Mit477 and D2Mit207 for LW
and between D2Mit207 and D2Mit101 for SW; Table 4).
On chromosome 7, BW showed a two-peak proﬁle
(Fig. 2); however, only the maternal QTL placed between
Table 3 Number of phenotypic records and summary statistics for
the analyzed traits
Trait n Mean ± SE
Chromosome 2 subcongenics
Weight at 2 weeks of age (g) 2541 7.467 ± 0.025
Weight at 3 weeks of age (g) 2553 10.688 ± 0.035
Weight at 6 weeks of age (g) 2544 25.741 ± 0.085
Weight at 9 weeks of age (g) 2548 30.200 ± 0.111
Liver weight (g) 2531 1.339 ± 0.005
Spleen weight (g) 2527 0.098 ± 0.001
Kidneys weight (g) 2532 0.316 ± 0.001
Heart weight (g) 2526 0.149 ± 0.001
Testis weight (g) 1636 0.130 ± 0.002
Gonadal fat pads weight (g) 2527 0.392 ± 0.002
Retroperitoneal fat pad weight (g) 2527 0.079 ± 0.001
Mesenteric fat pad weight (g) 2527 0.230 ± 0.001
Femoral fat pads weight (g) 2527 0.345 ± 0.002
Total fat pads weight (g) 2525 1.045 ± 0.005
Chromosome 7 subcongenics
Body length (cm) 775 9.822 ± 0.010
Body weight (g) 780 26.593 ± 0.105
Gonadal fat pads weight (g) 780 0.556 ± 0.011
Retroperitoneal fat pad weight (g) 774 0.195 ± 0.005
Mesenteric fat pad weight (g) 779 0.171 ± 0.004
Femoral fat pads weight (g) 780 0.311 ± 0.006
Total fat pads weight (g) 780 1.233 ± 0.024
Carcass weight (g) 766 24.871 ± 0.102
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123markers D7Mit301 and D7Mit373 (OR 7.7–7.9) remained
signiﬁcant after the joint analysis of both QTL
(P = 4.15 9 10
-7). Maternal QTL for BL and CW were
detected between D7Mit62 and D7Mit301 (P = 1.34 9
10
-5; OR 7.5–7.7) and between D7Mit373 and D7Mit321
(P = 2.32 9 10
-5; OR 7.9–7.11), respectively. All three
maternal QTL implied a reduction in body weight and
length linked with B6.C-H1 alleles (Table 4).
The maternal QTL accounted for a signiﬁcant percent-
age of the phenotypic variance, between 1.9% (9WK) and
11.7% (KW) for chromosome 2 QTL and between 2.4%
(CW) and 8.9% (BW) for chromosome 7 QTL (Table 4).
These values were similar or slightly larger than those
obtained by the direct effect of the offspring’s genotype,
OORj, in the same genomic regions (between 3.4
and 7.5%).
Maternal QTL for fat pad weight on mouse
chromosomes 2 and 7
Chromosome 2 maternal QTL for fat pad weights had
similar proﬁles, although MFP did not reach statistical
signiﬁcance (Fig. 1). A hotspot for genetic maternal con-
tribution to offspring obesity was detected between mark-
ers D2Mit477 and D2Mit101 (OR 2.5 and 2.6), although
maximum peaks were placed between D2Mit207 and
D2Mit101 (P B 2.81 9 10
-5; OR 2.6). The effect was
favorable to CAST/EiJ alleles promoting obesity in all
cases, with increases in fat pad weight ranging between
0.011 ± 0.002 g (RFP) and 0.087 ± 0.019 (TFP; Table 4).
These maternal QTL accounted for 2.1% (RFP) to 7.2%
(GFP and TFP) of the phenotypic variance (Table 4),
similar to the values accounted for by the direct effect of
the offspring’s genotype, OORj.
Chromosome 7 P-value proﬁles for GFP, RFP, FFP, and
TFP were very similar, whereas MFP showed slight dis-
crepancies (Fig. 2). Although two maternal QTL were
initially detected for MFP, only the one in marker D7Mit90
could be accepted after joint analysis (P = 7.48 9 10
-5).
The remaining traits showed two signiﬁcant maternal QTL
each, even after the joint analysis of both QTL. Maximum
signiﬁcances for the joint analysis of both QTL were
obtained between markers D7Mit90 and D7Mit62
(P = 1.36 9 10
-5; OR 7.4) and between markers
Table 4 Maternal QTL in
mouse chromosomes 2 and 7
(single-QTL analysis)
a 9WK Weight at 9 weeks of
age, BL Body length, BW Body
weight, CW Carcass weight, LW
Liver weight, SW Spleen
weight, KW Kidneys weight,
TW Testes weight,
GFP Gonadal fat pads weight,
RFW Retroperitoneal fad pads
weight, MFW Mesenteric fat
pad weight, FFP Femoral fad
pads weight, TFP Total fad
pads weight
b When a QTL spanned two or
more overlapping regions,
estimates were focused on the
region with smaller P value
c Estimates as the difference
between donor and background
genetic environments
d Percentage of the phenotypic
variance accounted for by the
maternal QTL
Trait
a Boundary microsatellites P value
b QTL effect
b,c Phenotypic
variance
d (%)
Chromosome 2
9WK (g) D2Mit185 to D2Mit207 1.23 9 10
-5 -0.828 ± 0.233 1.9
LW (g) D2Mit185 to D2Mit101 3.50 9 10
-7 -0.065 ± 0.012 2.5
SW (g) D2Mit185 to D2Mit101 1.46 9 10
-7 -0.006 ± 0.001 1.3
KW (g) D2Mit329 to D2Mit94 8.55 9 10
-8 0.036 ± 0.006 11.7
KW (g) D2Mit107 to D2Mit194 1.12 9 10
-6 -0.022 ± 0.004 9.7
TW (g) D2Mit185 to D2Mit101 6.32 9 10
-7 0.010 ± 0.001 5.4
TW (g) D2Mit107 to D2Mit194 6.96 9 10
-8 -0.020 ± 0.003 3.1
GFP (g) D2Mit185 to D2Mit101 1.62 9 10
-5 0.038 ± 0.008 7.2
RFP (g) D2Mit185 to D2Mit101 2.81 9 10
-5 0.011 ± 0.002 2.1
FFP (g) D2Mit185 to D2Mit101 5.81 9 10
-7 0.027 ± 0.005 3.7
TFP (g) D2Mit185 to D2Mit101 6.83 9 10
-6 0.087 ± 0.019 7.2
Chromosome 7
BL (cm) D7Mit62 to D7Mit301 1.34 9 10
-5 -0.126 ± 0.039 3.3
BW (g) D7Mit90 to D7Mit373 1.90 9 10
-8 -2.176 ± 0.484 8.9
CW (g) D7Mit373 to D7Mit321 2.32 9 10
-5 -1.083 ± 0.354 2.4
GFP (g) D7Mit90 to D7Mit62 1.44 9 10
-7 -0.171 ± 0.042 7.6
GFP (g) D7Mit301 to D7Mit373 2.34 9 10
-9 -0.238 ± 0.049 9.7
RFP (g) D7Mit90 to D7Mit62 2.07 9 10
-7 -0.075 ± 0.013 5.0
RFP (g) D7Mit301 to D7Mit373 1.79 9 10
-7 -0.093 ± 0.022 7.2
MFP (g) D7Mit90 to D7Mit90 1.62 9 10
-5 -0.044 ± 0.014 2.7
MFP (g) D7Mit301 to D7Mit301 9.67 9 10
-5 -0.043 ± 0.015 2.5
FFP (g) D7Mit90 to D7Mit62 8.58 9 10
-7 -0.093 ± 0.024 6.1
FFP (g) D7Mit301 to D7Mit373 2.17 9 10
-6 -0.110 ± 0.029 6.9
TFP (g) D7Mit90 to D7Mit62 2.78 9 10
-7 -0.380 ± 0.097 2.5
TFP (g) D7Mit301 to D7Mit373 4.89 9 10
-8 -0.496 ± 0.114 2.7
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123D7Mit301 and D7Mit373 (P = 3.81 9 10
-6; OR 7.8).
Nevertheless, all OR between 7.4 and 7.9 showed signiﬁ-
cant estimates, with the exception of OR 7.7 characterized
by marker D7Mit301. All fat pad maternal QTL showed
negative estimates, indicating that maternal B6.C-H1
alleles contributed to leaner offspring 4–4.5 months after
birth. The maternal QTL accounted for a signiﬁcant per-
centage of the phenotypic variance, between 2.5% (MFP
and TFP) and 9.7% (GFP).
Discussion
Maternal QTL are scarce in the scientiﬁc literature (Jarvis
et al. 2005; Wolf et al. 2002). While numerous gene-
mapping studies have dissected the mouse genome for
direct effects on phenotypic traits, maternal genetic effects
have often been ignored or roughly accounted for in QTL
models. Maternal genetic effects cannot be addressed in
standard F2 designs because all F1 mothers are genetically
identical and the maternal contribution is reduced to
environmental genetic effects. The unique experimental
design in this study examining the F2 progeny originating
from overlapping subcongenics provides a very powerful
tool to dissect maternal QTL. The indirect effect of a
female’s genotype on her offspring’s phenotype (Mousseau
and Fox 1998a) can account for much of the phenotypic
variance (Hager et al. 2008) and occasionally contribute
signiﬁcant variation in traits expressed later in life
(Mousseau and Fox 1998b). Analyses of maternal QTL
require appropriate experimental designs and statistical
methods should take into account that the genetic back-
ground of each female could contribute three times to her
offspring, ﬁrst by the direct inheritance of DNA, second
through the maternal in utero environment, and third by the
maternal postpartum environment during nursing. Under
some experimental designs (Hager et al. 2008), maternal
genetic effects and imprinting effects could be difﬁcult to
differentiate. Our study distinguishes direct genetic effects
from the combined effects of both maternally provided in
utero and postpartum environments. No recombinant F2
mice were included in the analysis in order to properly
account for the direct genetic contribution of each indi-
vidual through the effects of the subcongenic strain and the
offspring genotype in the chromosomal overlapping region
of interest. The two types of maternally provided envi-
ronments could be distinguished only by using cross-fos-
tering studies. Genomic imprinting cannot be addressed
under the F2 experimental design because the F1 hetero-
zygous females (and males) can give rise to both of the
reciprocal heterozygotes (background/donor and donor/
background, given as paternal/maternal), instead of the
experimental designs involving homozygous dams
(Bartolomei and Tilghman 1997; Hayward et al. 1998;
Reik and Walter 2001). The origin of each allele cannot be
identiﬁed; therefore, maternal (and paternal) imprinting
effects cannot be completely discarded in our study.
Our use of subcongenic strains allows for a novel
approach to QTL analysis, ﬁrst applied by Clee et al.
(2006) for mapping direct QTL in congenic mice. QTL
effects within each overlapping region between strains can
be directly assessed as the difference between donor and
background subcongenic strains at a given chromosomal
location. In this study, the approach described by Clee et al.
(2006) has been adapted for the identiﬁcation of maternal
QTL, after accounting for the remaining sources of
variation.
We report the identiﬁcation of several signiﬁcant
maternal QTL on mouse chromosomes 2 and 7, all of them
related to growth and obesity traits at later ages. A hotspot
was detected in mouse chromosome 2 between 104.5 and
114.8 Mb (OR 2.5–2.6). In this region, the donor alleles of
the maternal QTL were responsible for both lighter (9WK,
BW, and LW) and fatter (GFP, RFP, FFP, and TFP) off-
spring (Fig. 1, Table 4). Additional maternal QTL inﬂu-
encing the weight of the spleen, kidneys, and testis were
also reported in Fig. 1. On mouse chromosome 7, growth
maternal QTL peaked between 98.7 and 103.2 Mb (OR
7.7–7.9), whereas obesity maternal QTL showed signiﬁ-
cant estimates between 87.5 and 103.2 Mb, with a non-
signiﬁcant gap on OR 7.7 (*98.7 Mb). Note that the
length and boundaries of this nonsigniﬁcant genomic
region linked with marker D7Mit301 cannot be properly
established. This is due to the presence of unknown donor
alleles to the left and right of D7Mit301 in B6.C-A, B6.C-
B, and B6.C-L subcongenic strains that can extend up to
D7Mit62 (left side) and D7Mit373 (right side). Neverthe-
less, this does not invalidate the two signiﬁcant maternal
QTL at the left and right of D7Mit301. All the maternal
effect QTL accounted for a substantial percentage of the
phenotypic variance (1.9-11.7%), agreeing with values
reported by Wolf et al. (2002). This result highlights the
importance of the maternal genome to the offspring’s
phenotype at latter ages. Although this source of variation
is often ignored in QTL analyses, our results suggest that
maternal effect QTL could be a common and signiﬁcant
source of genetic variation affecting growth and obesity.
Maternal QTL donor alleles caused lighter (BW; Table 4)
and leaner (GFP, RFP, FFP, and TFP) F2 mice (Table 4).
Our model included the random environmental effect of
each litter in order to account for all the remaining litter-
speciﬁc nongenetic sources of variation (e.g., feeding,
temperature). Within this context, only maternal effects
with a genetic basis were addressed by the reported QTL.
All phenotypic traits involved in signiﬁcant maternal QTL
on chromosome 2 were recorded in 2-month-old mice
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1236 weeks after weaning and without additional contacts with
their mother after the weaning date. The phenotypic traits
involved in signiﬁcant maternal QTL on chromosome 7
were recorded in 4–4.5-month-old mice. Within this con-
text, these delayed indirect maternal genetic contributions
must be related to biological mechanisms initiated during
fetal or postnatal life and preserved for enough time to
substantially modulate the adult phenotype.
According to our survey of the literature, maternal QTL
for post-weaning mouse growth are limited to a study by
Hager et al. (2008), and maternal QTL for obesity traits in
adult mice were ﬁrst suggested by Jarvis et al. (2005).
However, the analysis of maternal effects at later ages has
been a ﬁeld of intense research in animals and humans.
This phenomenon is known as fetal programming (Drake
and Walker 2004), with the primary hypothesis being that a
stimulus or insult acting during critical stages of growth
and development may permanently alter tissue structure
and function (Barker and Clarck 1997). Gestation and early
neonatal life must be considered as potential sources of
indirect maternal genetic inﬂuences on offspring. During
the gestational period, levels of maternal gene products
involved in placenta development may inﬂuence gene
expression in the fetus. In addition, there is a ﬂow of
glucose, hormones, and amino acids from mother to off-
spring that could affect fetus growth and development
(Myatt 2006). It has also been shown that during gestation,
maternal methyl supplements affect epigenetic variation
and DNA methylation of offspring (Cooney et al. 2002).
On the other hand, the early neonatal period plays a key
role in the development of the immune system (Wheeler
et al. 2007) and formation of the hypothalamus-pituitary-
adrenal axis. Maternal care and milk quality may inﬂuence
the formation of both of these systems. In species that give
birth to immature young (e.g., mice, rats, and rabbits),
much neuroendocrine development occurs in the postnatal
period (Kapoor et al. 2006). However, in humans and
nonhuman primates, these developmental stages occur in
utero. During neuroendocrine development, hormones cir-
culating in the mother’s body can directly regulate the
development and activity of the fetus’s central nervous
system (Simerly 2002, 2005; Bouret and Simerly 2006). In
fact, the formation of the hypothalamus-pituitary-adrenal
axis could be one of the most reliable ways to maternally
modify growth and adult fat pads of the offspring, given the
close relation of the neuroendocrine system to growth and
fat metabolism (Bjo ¨rntorp 1997;M u ¨ller et al. 1999).
Obviously, all these biological mechanisms present a
complex scenario in which the reported maternal QTL
could be due to multiple genes involved in very different
physiologic pathways.
The analysis of maternal QTL on the basis of overlap-
ping subcongenic strains examines each genomic region
separately; thus, any one gene in the signiﬁcant genomic
region may have a causative mutation. Although our
approach allowed us to ﬁne-map maternal QTL to rela-
tively small genomic regions of less than 5 Mb, we can
only suggest some plausible candidate genes. Several genes
are valid candidates in the hotspot of mouse chromosome 2
(104.5–114.8 Mb). The acyltransferase-like 3 (Agpat7)
gene and the gamma-butyrobetaine dioxygenase (Bbox1)
gene are involved in phospholipid and carnitine biosyn-
thetic processes, respectively. Both biosynthetic pathways
have important effects during fetal life and the suckling
period (Oey et al. 2006; Shennan and Peaker 2000). The
brain-derived neurotrophic factor isoform 1 (Bdnf1) gene
inﬂuences morphology and function of the brain (Liu et al.
2006). Bdnf1 is also expressed in the mammary gland and
potentially plays a role in fat deposition. In addition, sec-
retogranin 5 (Scg5) is one of the most promising candidate
genes for growth and fat pad weight maternal QTL in
chromosome 2, given the previously reported overexpres-
sion in our population of subcongenic mice (Farber et al.
2008). For the second maternal QTL region reported in
chromosome 7 (OR 7.4–7.6), only one candidate gene can
be reported. Prolyl carboxypeptidase (Prcp) is located at
100.0 Mb and is expressed in several tissues including
hypothalamic neurons (Garcı ´a-Horsman et al. 2007). It has
several known substrates including kallikrein and angio-
tensin II. Thus, Prcp could be a potential candidate
maternal effects gene.
Our ﬁndings provide further evidence of the potentially
important role maternal genetic effects may play in the
determination of growth and body weight phenotypes. It is
generally accepted that direct genetic effects modulate
obesity, but the evidence presented here shows that
maternal genetic effects can play a key role in fat deposi-
tion in adult mice. This is an important starting point to
study the genetic basis of fetal programming. In addition,
our results support the generation and maintenance of
subcongenic strains as an important research tool, given
that they can be used to characterize and ﬁne-map genomic
regions contributing to phenotypic traits of interest and
maternal effects, as described here. Although our experi-
mental design did not allow for the identiﬁcation of speciﬁc
genetic mechanisms involved in the maternal QTL, the
genomic regions of interest were ﬁne-mapped to small
sections of chromosomes 2 and 7 spanning less than
10 Mb. Further investigation using our set of subcongenic
strains, as well as generation of additional subcongenic
strains, will contribute to the characterization of mutations
underlying the reported maternal QTL.
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